Editorial

Current Topics in Medicinal Chemistry

Volumn 13, Issue 3, 2013, Pages 241-243

  Kaneko, Yosuke ^a   Szallasi, Arpad ^b  

^a ONO PHARMACEUTICAL CO   (Japan)

^b MONMOUTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D 3263; GLENMARK; GRC 17536; SAR 292833; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR 4;

BLADDER DISEASE; BONE DISEASE; CHRONIC PAIN; CLINICAL RESEARCH; COUGHING; EDITORIAL; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC DISORDER; HEAT SENSATION; HUMAN; HYPERTHERMIA; HYPOCALCEMIA; HYPOMAGNESEMIA; KIDNEY POLYCYSTIC DISEASE; NEUROPATHIC PAIN; OVERACTIVE BLADDER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; SIDE EFFECT; SOLID TUMOR; X RAY CRYSTALLOGRAPHY; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASES; DRUG DEVELOPMENT; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; DRUG ANTAGONISM;

ANIMALS; DISEASE; DRUG DISCOVERY; HUMANS; MOLECULAR TARGETED THERAPY; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84876704085     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026611313030001     Document Type: Editorial

References (35)

1. Szallasi, A.,; Seta, M. Targeting TRPV1 for pain relief: limits, losers and laurels. Exp. Opin. Investig. Drugs, 2012, 21(9), 1351-1369.
2. Krakow, D.; Vriens, J.; Camacho, N.; Luong, P.; Deixler, H.; Funari, T.L.; Bacino, C.A.; Irons, M.B.; Holm, I.A.; Sadler, L.; Okenfuss, E.B.; Janssens, A.; Voets, T.; Rimoin, D.L.; Lachman, R.S.; Nilius, B.; Cohn, D.H. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am. J. Hum. Genet., 2009, 84(3), 307-315.
3. Auer-Grumbach, M.; Olschewski, A.; Papić, L.; Kremer, H.; McEntagart, M.E.; Uhrig, S.; Fischer, C.; Fröhlich, E.; Bálint, Z.; Tang, B.; Strohmaier, H.; Lochmüller, H.; Schlotter-Weigel, B.; Senderek, J.; Krebs, A.; Dick, K. J.; Petty, R.; Longman, C.; Anderson, N.E.; Padberg, G.W.; Schelhaas, H.J.; van Ravenswaaij-Arts, C.M.; Pieber, T.R.; Crosby, A.H.; Guelly, C. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat. Genet., 2010, 42(2), 160-164.
4. Landouré G.; Zdebik, A.A.; Martinez, T.L.; Burnett, B.G.; Stanescu, H.C.; Inada, H.; Shi, Y.; Taye, A.A.; Kong, L.; Munns, C.H.; Choo, S.S.; Phelps, C.B.; Paudel, R.; Houlden, H.; Ludlow, C.L.; Caterina, M.J.; Gaudet, R.; Kleta, R.; Fischbeck, K.H.; Sumner, C.J. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat. Genet., 2010, 42(2), 170-174.
5. Feng, S.; Okenka, G.M.; Bai, C.X.; Streets, A.J.; Newby, L.J.; DeChant, B.T.; Tsiokas, L.; Obara, T.; Ong, A.C. Identification and functional characterization of an N-terminal oligomerization domain for polycystin-2. J. Biol. Chem., 2008, 283(42), 28471-28479.
6. Winn, M.P.; Conlon, P.J.; Lynn, K.L.; Farrington, M.K.; Creazzo, T.; Hawkins, A.F.; Daskalakis, N.; Kwan, S.Y.; Ebersviller, S.; Burchette, J.L.; Pericak-Vance, M.A.; Howell, D.N.; Vance, J.M.; Rosenberg, P.B. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science, 2005, 308(5729), 1801-1804.
7. Reiser, J.; Polu, K.R.; Möller, C.C.; Kenlan, P.; Altintas, M.M.; Wei, C.; Faul, C.; Herbert, S.; Villegas, I.; Avila-Casado, C.; McGee, M.; Sugimoto, H.; Brown, D.; Kalluri, R.; Mundel, P.; Smith, P.L.; Clapham, D.E.; Pollak, M. R. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet., 2005, 37(7), 739-744.
8. Schlingmann, K.P.; Weber, S.; Peters, M.; Niemann Nejsum, L.; Vitzthum, H.; Klingel, K.; Kratz, M.; Haddad, E.; Ristoff, E.; Dinour, D.; Syrrou, M.; Nielsen, S.; Sassen, M.; Waldegger, S.; Seyberth, H.W.; Konrad, M. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat. Genet., 2002, 31(2), 166-170.
9. Walder, R.Y.; Landau, D.; Meyer, P.; Shalev, H.; Tsolia, M.; Borochowitz, Z.; Boettger, M.B.; Beck, G.E.; Englehardt, R.K.; Carmi, R.; Sheffield, V.C. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat. Genet., 2002, 31(2), 171-174.
10. Dong, X.P.; Cheng, X.; Mills, E.; Delling, M.; Wang, F.; Kurz, T.; Xu, H. The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature, 2008, 455(7215), 992-996.
11. Moran, M.M.; McAlexander, M.A.; Bíró, T.; Szallasi, A. Transient receptor potential channels as therapeutic targets. Nat. Rev. Drug Discov., 2011, 10(8), 601-620.
12. Kremeyer, B.; Lopera, F.; Cox, J.J.; Momin, A.; Rugiero, F.; Marsh, S.; Woods, C.G.; Jones, N.G.; Paterson, K.J.; Fricker, F.R.; Villegas, A.; Acosta, N.; Pineda-Trujillo, N.G.; Ramírez, J.D.; Zea, J.; Burley, M.W.; Bedoya, G.; Bennett, D.L.; Wood, J.N.; Ruiz-Linares, A.A gain-of-function mutation in TRPA1 causes familial episodic pain syndrome. Neuron, 2010, 66(5), 671-680.
13. Khairatkar, J.; Maharaj, N.; Thomas, A. The TRPV3 Receptor as a Pain Target: A Therapeutic Promise or Just Some More New Biology? Open Drug Discov. J., 2010, 2, 89-97.
14. Haraguchi, K.; Kawamoto, A.; Isami, K.; Maeda, S.; Kusano, A.; Asakura, K.; Shirakawa, H.; Mori, Y.; Nakagawa, T.; Kaneko, S. TRPM2 contributes to inflammatory and neuropathic pain through the aggravation of pronociceptive inflammatory responses in mice. J. Neurosci., 2012, 32(11), 3931-3941.
15. Vriens, J.; Owsianik, G.; Hofmann, T.; Philipp, S.E.; Stab, J.; Chen, X.; Benoit, M.; Xue, F.; Janssens, A.; Kerselaers, S.; Oberwinkler, J.; Vennekens, R.; Gudermann, T.; Nilius, B.; Voets, T. TRPM3 is a nociceptor channel involved in the detection of noxious heat. Neuron, 2011, 70(3), 482-494.
16. Colburn, R.W.; Lubin, M.L.; Stone, D.J. Jr; Wang, Y.; Lawrence, D.; D'Andrea, M.R.; Brandt, M.R.; Liu, Y.; Flores, C.M.; Qin, N. Attenuated cold sensitivity in TRPM8 null mice. Neuron, 2007, 54(3), 379-386.
17. Preti, D.; Szallasi, A.; Patacchini, R. TRP channels as therapeutic targets in airway disorders: a patent review. Expert Opin. Ther. Pat., 2012, 22(6), 663-695.
18. Caceres, A. I.; Brackmann, M.; Elia, M.D.; Bessac, B.F.; del Camino, D.; D'Amours, M.; Witek, J.S.; Fanger, C.M.; Chong, J.A.; Hayward, N.J.; Homer, R.J.; Cohn, L.; Huang, X.; Moran, M.M.; Jordt, S.E. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc. Natl. Acad. Sci. U S A, 2009, 106(22), 9099-9104.
19. Jia, Y.; Wang, X.; Varty, L.; Rizzo, C.A.; Yang, R.; Correll, C.C.; Phelps, P. T.; Egan, R. W.; Hey, J. A. Functional TRPV4 channels are expressed in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol., 2004, 287(2), 272-278.
20. Xiao, J. H.; Xiao, J. H.; Zheng, Y.M.; Liao, B.; Wang, Y.X. Functional role of canonical transient receptor potential 1 and canonical transient receptor potential 3 in normal and asthmatic airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol., 2010, 43(1), 17-25.
21. Weissmann, N.; Dietrich, A.; Fuchs, B.; Kalwa, H.; Ay, M.; Dumitrascu, R.; Olschewski, A.; Storch, U.; Mederos, Y.; Schnitzler, M.; Ghofrani, H. A.; Schermuly, R.T.; Pinkenburg, O.; Seeger, W.; Grimminger, F.; Gudermann, T. Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange. Proc. Natl. Acad. Sci. U S A, 2006, 103(50), 19093-19098.
22. Sabnis, A.S.; Reilly, C.A.; Veranth, J.M.; Yost, G.S. Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures. Am. J. Physiol. Lung Cell. Mol. Physiol., 2008, 295(1), 194-200.
23. Weisshaar, E.; Heyer, G.; Forster, C.; Handwerker, H.O. Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin. Arch. Dermatol. Res., 1998, 290(6), 306-311.
24. Tóth, B.I.; Dobrosi, N.; Dajnoki, A.; Czifra, G.; Oláh, A.; Szöllosi, A.G.; Juhász, I.; Sugawara, K.; Paus, R.; Bíró, T. Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J. Invest. Dermatol., 2011, 131(5), 1095-1104.
25. Yoshioka, T.; Imura, K.; Asakawa, M.; Suzuki, M.; Oshima, I.; Hirasawa, T.; Sakata, T.; Horikawa, T.; Arimura, A. Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. J. Invest. Dermatol., 2009, 129(3), 714-722.
26. Peier, A.M.; Reeve, A.J.; Andersson, D.A.; Moqrich, A.; Earley, T.J.; Hergarden, A.C.; Story, G.M.; Colley, S.; Hogenesch, J.B.; McIntyre, P.; Bevan, S.; Patapoutian, A. A heat-sensitive TRP channel expressed in keratinocytes. Science, 2002, 296(5575), 2046-2049.
27. Birder, L.A. TRPs in bladder diseases. Biochim. Biophys. Acta, 2007, 1772(8), 879-884.
28. Birder, L.A.; Nakamura, Y.; Kiss, S.; Nealen, M.L.; Barrick, S.; Kanai, A. J.; Wang, E.; Ruiz, G.; De Groat, W.C.; Apodaca, G.; Watkins, S.; Caterina M. J. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat. Neurosci., 2002, 5(9), 856-860.
29. Gevaert, T.; Vriens, J.; Segal, A.; Everaerts, W.; Roskams, T.; Talavera, K.; Owsianik, G.; Liedtke, W.; Daelemans, D.; Dewachter, I.; Van Leuven, F.; Voets, T.; De Ridder, D.; Nilius, B. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J. Clin. Invest., 2007, 117(11), 3453-3462.
30. Mukerji, G.; Yiangou, Y.; Corcoran, S.L.; Selmer, I.S.; Smith, G.D.; Benham, C.D.; Bountra, C.; Agarwal, S.K.; Anand, P. Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urol., 2006, 6, 6.
31. Lehen'kyi, V.; Prevarskaya, N. Oncogenic TRP channels. Adv. Exp. Med. Biol., 2011, 704, 929-945.
32. McInnes, C., and Fischer, P. M. Strategies for the design of potent and selective kinase inhibitors. Curr. Pharm. Des., 2005, 11(14), 1845-1863.
33. Agrawal, M.; Garg, R.J.; Cortes, J.; Quintás-Cardama, A. Tyrosine kinase inhibitors: the first decade. Curr. Hematol. Malig. Rep., 2010, 5(2), 70-80.
34. Li, M., Yu, Y., Yang, J. Structural biology of TRP channels. Adv. Exp. Med. Biol., 2011, 704, 1-23.
35. Jacobson, K.A., and Costanzi, S., New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors. Mol. Pharmacol., 2012, 82(3), 361-71.